Suppr超能文献

人骨肉瘤细胞系中11β-羟基类固醇脱氢酶活性及皮质类固醇受体表达的特征分析

Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.

作者信息

Bland R, Worker C A, Noble B S, Eyre L J, Bujalska I J, Sheppard M C, Stewart P M, Hewison M

机构信息

Department of Medicine, Institute of Clinical Research, Queen Elizabeth Hospital, The University of Birmingham, Birmingham B15 2TH, UK.

出版信息

J Endocrinol. 1999 Jun;161(3):455-64. doi: 10.1677/joe.0.1610455.

Abstract

Studies in vitro and in vivo have shown that corticosteroids play an important role in bone physiology and pathophysiology. It is now established that corticosteroid hormone action is regulated, in part, at the pre-receptor level through the expression of isozymes of 11beta-hydroxysteroid dehydrogenase (11beta-HSD), which are responsible for the interconversion of hormonally active cortisol to cortisone. In this report we demonstrate 11beta-HSD activity in human osteoblast (OB) cells. Osteosarcoma-derived OB cell lines TE-85, MG-63 and SaOS-2 and fibrosarcoma Hs913T cells express the type 2 isoform of 11beta-HSD, as determined by reverse transcription polymerase chain reaction (RT-PCR) and specific enzyme assays. Enzyme activity was shown to be strictly NAD dependent with a Km of approximately 71 nM; 11beta-HSD type 1 mRNA expression and enzyme activity were not detected. All four cell lines expressed mRNA for the glucocorticoid receptor (GR) and mineralocorticoid receptor, but specific binding was only detectable with radiolabelled dexamethasone (Kd=10 nM) and not aldosterone. MG-63 cells had two to three times more GR than the other OB cells, which correlated with the higher levels of 11beta-HSD 2 activity in these cells. In contrast to the osteosarcoma cell studies, RT-PCR analysis of primary cultures of human OB cells revealed the presence of mRNA for 11beta-HSD 1 as well as 11beta-HSD 2. However, enzyme activity in these cells remained predominantly oxidative, i.e. inactivation of cortisol to cortisone (147 pmol/h per mg protein at 500 nM cortisol) was greater than cortisone to cortisol (10.3 pmol/h per mg protein at 250 nM cortisone). Data from normal human OB and osteosarcoma cells demonstrate the presence of an endogenous mechanism for inactivation of glucocorticoids in OB cells. We postulate that expression of the type 1 and type 2 isoforms of 11beta-HSD in human bone plays an important role in normal bone homeostasis, and may be implicated in the pathogenesis of steroid-induced osteoporosis.

摘要

体外和体内研究表明,皮质类固醇在骨生理和病理生理中发挥重要作用。现已确定,皮质类固醇激素作用部分在受体前水平通过11β-羟基类固醇脱氢酶(11β-HSD)同工酶的表达来调节,这些同工酶负责将具有激素活性的皮质醇转化为可的松。在本报告中,我们展示了人成骨细胞(OB)中的11β-HSD活性。通过逆转录聚合酶链反应(RT-PCR)和特异性酶分析确定,骨肉瘤来源的OB细胞系TE-85、MG-63和SaOS-2以及纤维肉瘤Hs913T细胞表达11β-HSD的2型同工酶。酶活性显示严格依赖NAD,Km约为71 nM;未检测到11β-HSD 1型mRNA表达和酶活性。所有四种细胞系均表达糖皮质激素受体(GR)和盐皮质激素受体的mRNA,但仅用放射性标记的地塞米松(Kd = 10 nM)可检测到特异性结合,而醛固酮则不能。MG-63细胞的GR比其他OB细胞多两到三倍,这与这些细胞中较高水平的11β-HSD 2活性相关。与骨肉瘤细胞研究不同,人OB细胞原代培养物的RT-PCR分析显示存在11β-HSD 1以及11β-HSD 2的mRNA。然而,这些细胞中的酶活性仍主要为氧化型,即皮质醇转化为可的松(在500 nM皮质醇时为每毫克蛋白质147 pmol/h)大于可的松转化为皮质醇(在250 nM可的松时为每毫克蛋白质10.3 pmol/h)。来自正常人OB细胞和骨肉瘤细胞的数据表明,OB细胞中存在一种内源性糖皮质激素失活机制。我们推测,人骨中11β-HSD 1型和2型同工酶的表达在正常骨稳态中起重要作用,并且可能与类固醇诱导的骨质疏松症的发病机制有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验